‘The Ripple’ Podcast To Feature Ben&Ben, Moira, SB19, And More

This Monday, The Ripple podcast welcomes a lineup of music icons including Moira Dela Torre and SB19.

‘My Love Will Make You Disappear’ Makes PHP40 Million In Four Days

In its opening weekend, "My Love Will Make You Disappear" takes the box office by storm, earning PHP40 million.

DBM: Infra Spending Reaches PHP1.545 Trillion In 2024

Ang imprastraktura ng bansa ay umabot sa PHP1.545 trilyon sa 2024, nagpakita ng pagtaas na 8.9 porsyento mula sa nakaraang taon.

DSWD Uses Holistic Approach To Address Gender-Based Violence

DSWD patuloy na nagbibigay ng komprehensibong programa upang suportahan ang mga biktima at perpetrator ng karahasan batay sa kasarian.

Turkish Scientists Begin Testing Drug To Treat Advanced Cancer

Turkish scientists have begun the Phase 1 studies of a drug developed for patients with recurrent, metastatic, or advanced lung cancer.
By The Philippine Post

Turkish Scientists Begin Testing Drug To Treat Advanced Cancer

0
0

How do you feel about this story?

Like
Love
Haha
Wow
Sad
Angry

Turkish scientists have begun the Phase 1 studies of a drug developed for patients with recurrent, metastatic, or advanced lung cancer.

The Phase 1a study will involve 16 volunteers in total, and the researchers will determine the maximum tolerable dose for patients, while the Phase 1b study will focus on the medication’s efficacy and safety in 10 other patients.

Rana Nomak Sanyal, a chemistry professor at Bogazici University, and her team have developed the medicine.

Fevzi Altuntas, who is in charge of the Phase 1a research at Ankara Oncology Training and Research Hospital, told Anadolu Agency that scientists are working together to ensure that Turkiye has self-sufficiency in health to the level where it can develop its own medicines.

“The drug will be a beacon of hope for people with lung cancer. A new molecule, a targeted agent,” he said, adding that patients who tried standard treatments without success could benefit from the cure.

Altuntas added the hospital’s Clinical Research Center has taken on significant responsibilities at both the national and international levels.

He highlighted that the research center has conducted a number of studies, including 114 international Phase 2 and Phase 3 studies, a national virus-like particle (VLP) vaccine, Car-T-cell therapy, and seven Phase 1 cancer trials. (PNA)